The Dutch biotech’s SureTACs platform targets membrane proteins that have long eluded conventional drug discovery by engineering them out of existence rather than blocking them. Biovance Capital joins as new co-lead alongside Kurma Partners in a final close that brings the oversubscribed seed round to €17 million. Most drugs work by blocking proteins. They attach […]<br /> This story continues at The Next Web [...]
The London-based platform, which already covers 1.5 million eligible lives across enterprise and healthcare deployments, is using the Series A to accelerate US market entry and deepen its clinical inf [...]
Amazon Web Services (AWS) announced this Tuesday the launch of its AI bio tool, Amazon Bio Discovery, to accelerate the early-stage process of drug discovery in the pharmaceutical industry. The appl [...]
The Luxembourg-founded startup is already in production with multiple top-20 global pharma companies, including a public collaboration with Pfizer. Its $10M seed round is led by redalpine, with the CE [...]
Outset raises $17M Series A to scale its AI-moderated research platform used by Nestlé, Microsoft, and WeightWatchers that's 8x faster and 81% cheaper than traditional market research. [...]
By now, your brackets were likely busted a long time ago. The 2025 NCAA Tournaments, affectionately known to many as March Madness, are coming to a close. Both the men's and women's Final Fo [...]
The microbiome, the vast, tangled ecosystem of bacteria, fungi and other microbes that live in and on us, is increasingly recognised as a major factor in health, nutrition and drug response. A new sta [...]
Copenhagen-area AgTech startup Mycoverse has secured €2.4 million in pre-seed equity financing to advance a biological crop protection platform that uses fungi to replace or reduce chemical pesticid [...]